SpinalCure Australia

Introduction

eWalk trial study lead, Simon Gandevia, explains the trial and the vision

eWalk trial study lead, Simon Gandevia, explains the trial and the vision

Professor Simon Gandevia of NeuRA, lead scientist on the eWalk neurostimulation trial, explains how this gold standard trial is aiming to improve walking and other functions in people with incomplete spinal cord injury. This research was instigated by SpinalCure, and funded by SpinalCure and Catwalk NZ.

Donate to help build on this research and expand it to include a wider range of injuries and functions for people with spinal cord injury.